Michael Dale
Description Michael D. Dale, 50, has been Chief Executive Officer and President of ATS Medical since October 2002, and Chairman of the Board of Directors since May 2004. From 1998 to 2002, Mr. Dale was Vice President of Worldwide Sales and Marketing at Endocardial Solutions, Inc., a company that developed and marketed an advanced cardiac mapping and catheter navigation system for the diagnosis and treatment of cardiac arrhythmias. From 1996 to 1998, Mr. Dale was Vice President of Global Sales for Cyberonics, Inc., a neuromodulation medical device company, and additionally was Managing Director of Cyberonics Europe S.A. From 1988 to 1996, Mr. Dale served in several capacities at cardiovascular medical device manufacturer and marketer St. Jude Medical, Inc., most recently as the Business Unit Director for St. Jude Medical Europe. At present, Mr. Dale serves on the board of directors of Neuronetics, Inc., the world?s leader in Transcranial Magnetic Stimulation Therapy, which involves the use of MRI-strength magnetic fields to stimulate nerve cells in the brain for the treatment of patients suffering from depression. Mr. Dale also serves on the board of directors of Rhythmia, Inc., an early stage medical technology company, and the Advanced Medical Technology Association (AdvaMed). Mr. Dale also served on the board of Enpath Medical, Inc., a medical products company that designs, develops, manufactures and markets percutaneous delivery solutions, from 2001 to 2005 (when the company was acquired). Upon the effectiveness of the Merger on August 12, 2010, ATS Medical?s existing executive officers resigned as executive officers of ATS Medical. To view the detailed information, you need to SUBSCRIBE with us. |
 |